Related Experiment Video
Updated: Aug 16, 2025

Porous Silicon Microparticles for Delivery of siRNA Therapeutics
Published on: January 15, 2015
Mesoporous Silica Nanoparticles-Based Nanoplatforms: Basic Construction, Current State, and Emerging Applications in
Yi Feng1, Zhen Liao1, Mengyue Li1
1Department of Pharmacy, Personalized Drug Therapy Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 611731, P. R. China.
Mesoporous silica nanoparticles (MSNs) offer unique properties for developing advanced anticancer drug delivery systems and bioimaging tools. This review highlights MSN synthesis, functionalization for controlled release, and their multimodal applications in cancer therapy.
Area of Science:
- Nanotechnology
- Materials Science
- Biomedical Engineering
Background:
- Nanoparticles are increasingly utilized for medical diagnostics and therapeutics.
- Mesoporous silica nanoparticles (MSNs) possess unique physicochemical properties suitable for drug delivery and bioimaging.
- MSNs can be engineered to carry both therapeutic and imaging agents for multimodal cancer treatment.
Purpose of the Study:
- To review recent advancements in MSNs synthesis for drug delivery and smart response applications.
- To discuss the design of functional MSN materials for controlled anticancer drug release.
- To highlight the use of MSNs in bioimaging and as multifunctional delivery vehicles.
Main Methods:
- Overview of synthetic strategies for various MSN architectures (ordered, hollow, core-shell, dendritic, biodegradable).
- Discussion of functionalization techniques for controlled drug release mechanisms.
- Summary of recent research on MSN-based bioimaging applications.
Main Results:
- Various MSN structures can be synthesized for tailored drug delivery.
- Functionalized MSNs enable controlled and responsive drug release for enhanced anticancer therapy.
- MSNs demonstrate significant potential in multimodal bioimaging and drug delivery.
Conclusions:
- MSNs are versatile platforms for developing synergistic anticancer drug delivery systems.
- Future research should focus on optimizing MSN design for improved therapeutic efficacy and imaging capabilities.
- Continued development of MSNs will advance personalized cancer treatment strategies.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drugs that Stabilize Microtubules

